APO Research
Talk to an analyst

APO RESEARCH · REPORT

C1-INH Replacement Therapy

Compare research editions
View pricing & licenses

Selected research

Market Outlook & Growth Opportunities

Global C1-INH Replacement Therapy Market Outlook and Growth Opportunities 2026

29 December 2025190 pages

Choose your research edition.

Industry ResearchC1-INH Replacement Therapy Industry Research Report 2026101 pages · $2,950 USDIndustry Growth & TrendsGlobal C1-INH Replacement Therapy Industry Growth and Trends Forecast to 203261 pages · $3,450 USDMarket StructureGlobal C1-INH Replacement Therapy Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032175 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal C1-INH Replacement Therapy Market Outlook and Growth Opportunities 2026190 pages · $4,250 USDMarket Analysis & ForecastGlobal C1-INH Replacement Therapy Market Analysis and Forecast 2026-2032197 pages · $4,950 USD

Market perspective

The global C1-INH Replacement Therapy market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for C1-INH Replacement Therapy is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for C1-INH Replacement Therapy is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for C1-INH Replacement Therapy is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the C1-INH Replacement Therapy market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the C1-INH Replacement Therapy market include CSL Behring, Pharming Healthcare and Takeda, among others. In 2025, the top three vendors together accounted for approximately % of global market revenue.

This report provides an overview of the global C1-INH Replacement Therapy market in terms of revenue and gross margin, analyzing global market trends using historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of C1-INH Replacement Therapy and market revenue by major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents C1-INH Replacement Therapy revenue, market share, and industry ranking for the main companies for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

Across the 2021-2026 period, the analysis compares revenue growth and profitability profiles by company, distinguishing participants with sustained expansion from those with more cyclical performance, and relates these patterns to differences in regional exposure, product portfolios, and application focus in the global C1-INH Replacement Therapy market.

C1-INH Replacement Therapy Segment by Company

CSL Behring

Pharming Healthcare

Takeda

C1-INH Replacement Therapy Segment by Type

Subcutaneous Injection

Intravenous Injection

C1-INH Replacement Therapy Segment by Application

Acquired Angioedema

Hereditary Angioedema

C1-INH Replacement Therapy Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global C1-INH Replacement Therapy status and future forecast, involving, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the C1-INH Replacement Therapy key companies, revenue, market share, and recent developments.

3. To split the C1-INH Replacement Therapy breakdown data by regions, type, companies, and application.

4. To analyze the global and key regions C1-INH Replacement Therapy market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify C1-INH Replacement Therapy significant trends, drivers, influence factors in global and regions.

6. To analyze C1-INH Replacement Therapy competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global C1-INH Replacement Therapy market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of C1-INH Replacement Therapy and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of C1-INH Replacement Therapy.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, global total market size.

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global C1-INH Replacement Therapy industry.

Chapter 3: Detailed analysis of C1-INH Replacement Therapy company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales value of C1-INH Replacement Therapy in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of key country in the world.

Chapter 7: Sales value of C1-INH Replacement Therapy in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.

Chapter 9: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. C1-INH Replacement Therapy Industry Trends Table 2. C1-INH Replacement Therapy Industry Drivers Table 3. C1-INH Replacement Therapy Industry Opportunities and Challenges Table 4. C1-INH Replacement Therapy Industry Restraints Table 5. Global C1-INH Replacement Therapy Revenue by Company (US$ Million) & (2021-2026) Table 6. Global C1-INH Replacement Therapy Revenue Share by Company (2021-2026) Table 7. Global C1-INH Replacement Therapy Company Ranking, (2024-2026) & (US$ Million) Table 8. Global C1-INH Replacement Therapy Key Company Manufacturing Base & Headquarters Table 9. Global C1-INH Replacement Therapy Company, Product Type & Application Table 10. Global C1-INH Replacement Therapy Company Establishment Date Table 11. Global Company Market Concentration Ratio (CR5 and HHI) Table 12. Global C1-INH Replacement Therapy by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 13. Mergers & Acquisitions, Expansion Table 14. Significant Companies of Subcutaneous Injection Table 15. Significant Companies of Intravenous Injection Table 16. Global C1-INH Replacement Therapy Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 17. Global C1-INH Replacement Therapy Sales Value by Type (2021-2026) & (US$ Million) Table 18. Global C1-INH Replacement Therapy Sales Value by Type (2027-2032) & (US$ Million) Table 19. Global C1-INH Replacement Therapy Sales Value Share by Type (2021-2026) Table 20. Global C1-INH Replacement Therapy Sales Value Share by Type (2027-2032) Table 21. Significant Companies of Acquired Angioedema Table 22. Significant Companies of Hereditary Angioedema Table 23. Global C1-INH Replacement Therapy Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 24. Global C1-INH Replacement Therapy Sales Value by Application (2021-2026) & (US$ Million) Table 25. Global C1-INH Replacement Therapy Sales Value by Application (2027-2032) & (US$ Million) Table 26. Global C1-INH Replacement Therapy Sales Value Share by Application (2021-2026) Table 27. Global C1-INH Replacement Therapy Sales Value Share by Application (2027-2032) Table 28. Global C1-INH Replacement Therapy Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 29. Global C1-INH Replacement Therapy Sales Value by Region (2021-2026) & (US$ Million) Table 30. Global C1-INH Replacement Therapy Sales Value Share by Region (2021-2026) Table 31. Global C1-INH Replacement Therapy Sales Value by Region (2027-2032) & (US$ Million) Table 32. Global C1-INH Replacement Therapy Sales Value Share by Region (2027-2032) Table 33. Global C1-INH Replacement Therapy Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 34. Global C1-INH Replacement Therapy Sales Value by Country (2021-2026) & (US$ Million) Table 35. Global C1-INH Replacement Therapy Sales Value Market Share by Country (2021-2026) Table 36. Global C1-INH Replacement Therapy Sales Value by Country (2027-2032) & (US$ Million) Table 37. Global C1-INH Replacement Therapy Sales Value Market Share by Country (2027-2032) Table 38. CSL Behring Company Information Table 39. CSL Behring Business Overview Table 40. CSL Behring C1-INH Replacement Therapy Revenue (US$ Million) and Gross Margin (2021-2026) Table 41. CSL Behring C1-INH Replacement Therapy Product Portfolio Table 42. CSL Behring Recent Development Table 43. Pharming Healthcare Company Information Table 44. Pharming Healthcare Business Overview Table 45. Pharming Healthcare C1-INH Replacement Therapy Revenue (US$ Million) and Gross Margin (2021-2026) Table 46. Pharming Healthcare C1-INH Replacement Therapy Product Portfolio Table 47. Pharming Healthcare Recent Development Table 48. Takeda Company Information Table 49. Takeda Business Overview Table 50. Takeda C1-INH Replacement Therapy Revenue (US$ Million) and Gross Margin (2021-2026) Table 51. Takeda C1-INH Replacement Therapy Product Portfolio Table 52. Takeda Recent Development Table 53. Research Programs/Design for This Report Table 54. Authors List of This Report Table 55. Secondary Sources Table 56. Primary Sources List of Figures Figure 1. C1-INH Replacement Therapy Product Image Figure 2. Global C1-INH Replacement Therapy Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global C1-INH Replacement Therapy Market Size (2021-2032) & (US$ Million) Figure 4. Global C1-INH Replacement Therapy Company Revenue Ranking in 2025 (US$ Million) Figure 5. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 6. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 7. Subcutaneous Injection Image Figure 8. Intravenous Injection Image Figure 9. Global C1-INH Replacement Therapy Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 10. Global C1-INH Replacement Therapy Sales Value Share 2021 VS 2025 VS 2032 Figure 11. Global C1-INH Replacement Therapy Sales Value Share by Type (2021-2032) Figure 12. Acquired Angioedema Image Figure 13. Hereditary Angioedema Image Figure 14. Global C1-INH Replacement Therapy Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 15. Global C1-INH Replacement Therapy Sales Value Share 2021 VS 2025 VS 2032 Figure 16. Global C1-INH Replacement Therapy Sales Value Share by Application (2021-2032) Figure 17. Global C1-INH Replacement Therapy Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 18. Global C1-INH Replacement Therapy Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 19. North America C1-INH Replacement Therapy Sales Value (2021-2032) & (US$ Million) Figure 20. North America C1-INH Replacement Therapy Sales Value Share by Country (%), 2025 VS 2032 Figure 21. Europe C1-INH Replacement Therapy Sales Value (2021-2032) & (US$ Million) Figure 22. Europe C1-INH Replacement Therapy Sales Value Share by Country (%), 2025 VS 2032 Figure 23. Asia-Pacific C1-INH Replacement Therapy Sales Value (2021-2032) & (US$ Million) Figure 24. Asia-Pacific C1-INH Replacement Therapy Sales Value Share by Country (%), 2025 VS 2032 Figure 25. South America C1-INH Replacement Therapy Sales Value (2021-2032) & (US$ Million) Figure 26. South America C1-INH Replacement Therapy Sales Value Share by Country (%), 2025 VS 2032 Figure 27. Middle East & Africa C1-INH Replacement Therapy Sales Value (2021-2032) & (US$ Million) Figure 28. Middle East & Africa C1-INH Replacement Therapy Sales Value Share by Country (%), 2025 VS 2032 Figure 29. USA C1-INH Replacement Therapy Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 30. USA C1-INH Replacement Therapy Sales Value Share by Type, 2025 VS 2032 & (%) Figure 31. USA C1-INH Replacement Therapy Sales Value Share by Application, 2025 VS 2032 & (%) Figure 32. Canada C1-INH Replacement Therapy Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 33. Canada C1-INH Replacement Therapy Sales Value Share by Type, 2025 VS 2032 & (%) Figure 34. Canada C1-INH Replacement Therapy Sales Value Share by Application, 2025 VS 2032 & (%) Figure 35. Mexico C1-INH Replacement Therapy Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 36. Mexico C1-INH Replacement Therapy Sales Value Share by Type, 2025 VS 2032 & (%) Figure 37. Mexico C1-INH Replacement Therapy Sales Value Share by Application, 2025 VS 2032 & (%) Figure 38. Germany C1-INH Replacement Therapy Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 39. Germany C1-INH Replacement Therapy Sales Value Share by Type, 2025 VS 2032 & (%) Figure 40. Germany C1-INH Replacement Therapy Sales Value Share by Application, 2025 VS 2032 & (%) Figure 41. France C1-INH Replacement Therapy Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 42. France C1-INH Replacement Therapy Sales Value Share by Type, 2025 VS 2032 & (%) Figure 43. France C1-INH Replacement Therapy Sales Value Share by Application, 2025 VS 2032 & (%) Figure 44. U.K. C1-INH Replacement Therapy Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 45. U.K. C1-INH Replacement Therapy Sales Value Share by Type, 2025 VS 2032 & (%) Figure 46. U.K. C1-INH Replacement Therapy Sales Value Share by Application, 2025 VS 2032 & (%) Figure 47. Italy C1-INH Replacement Therapy Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 48. Italy C1-INH Replacement Therapy Sales Value Share by Type, 2025 VS 2032 & (%) Figure 49. Italy C1-INH Replacement Therapy Sales Value Share by Application, 2025 VS 2032 & (%) Figure 50. Spain C1-INH Replacement Therapy Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 51. Spain C1-INH Replacement Therapy Sales Value Share by Type, 2025 VS 2032 & (%) Figure 52. Spain C1-INH Replacement Therapy Sales Value Share by Application, 2025 VS 2032 & (%) Figure 53. Russia C1-INH Replacement Therapy Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 54. Russia C1-INH Replacement Therapy Sales Value Share by Type, 2025 VS 2032 & (%) Figure 55. Russia C1-INH Replacement Therapy Sales Value Share by Application, 2025 VS 2032 & (%) Figure 56. Netherlands C1-INH Replacement Therapy Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 57. Netherlands C1-INH Replacement Therapy Sales Value Share by Type, 2025 VS 2032 & (%) Figure 58. Netherlands C1-INH Replacement Therapy Sales Value Share by Application, 2025 VS 2032 & (%) Figure 59. Nordic Countries C1-INH Replacement Therapy Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 60. Nordic Countries C1-INH Replacement Therapy Sales Value Share by Type, 2025 VS 2032 & (%) Figure 61. Nordic Countries C1-INH Replacement Therapy Sales Value Share by Application, 2025 VS 2032 & (%) Figure 62. China C1-INH Replacement Therapy Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 63. China C1-INH Replacement Therapy Sales Value Share by Type, 2025 VS 2032 & (%) Figure 64. China C1-INH Replacement Therapy Sales Value Share by Application, 2025 VS 2032 & (%) Figure 65. Japan C1-INH Replacement Therapy Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 66. Japan C1-INH Replacement Therapy Sales Value Share by Type, 2025 VS 2032 & (%) Figure 67. Japan C1-INH Replacement Therapy Sales Value Share by Application, 2025 VS 2032 & (%) Figure 68. South Korea C1-INH Replacement Therapy Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 69. South Korea C1-INH Replacement Therapy Sales Value Share by Type, 2025 VS 2032 & (%) Figure 70. South Korea C1-INH Replacement Therapy Sales Value Share by Application, 2025 VS 2032 & (%) Figure 71. India C1-INH Replacement Therapy Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 72. India C1-INH Replacement Therapy Sales Value Share by Type, 2025 VS 2032 & (%) Figure 73. India C1-INH Replacement Therapy Sales Value Share by Application, 2025 VS 2032 & (%) Figure 74. Australia C1-INH Replacement Therapy Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 75. Australia C1-INH Replacement Therapy Sales Value Share by Type, 2025 VS 2032 & (%) Figure 76. Australia C1-INH Replacement Therapy Sales Value Share by Application, 2025 VS 2032 & (%) Figure 77. Southeast Asia C1-INH Replacement Therapy Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 78. Southeast Asia C1-INH Replacement Therapy Sales Value Share by Type, 2025 VS 2032 & (%) Figure 79. Southeast Asia C1-INH Replacement Therapy Sales Value Share by Application, 2025 VS 2032 & (%) Figure 80. Brazil C1-INH Replacement Therapy Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 81. Brazil C1-INH Replacement Therapy Sales Value Share by Type, 2025 VS 2032 & (%) Figure 82. Brazil C1-INH Replacement Therapy Sales Value Share by Application, 2025 VS 2032 & (%) Figure 83. Argentina C1-INH Replacement Therapy Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 84. Argentina C1-INH Replacement Therapy Sales Value Share by Type, 2025 VS 2032 & (%) Figure 85. Argentina C1-INH Replacement Therapy Sales Value Share by Application, 2025 VS 2032 & (%) Figure 86. Chile C1-INH Replacement Therapy Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 87. Chile C1-INH Replacement Therapy Sales Value Share by Type, 2025 VS 2032 & (%) Figure 88. Chile C1-INH Replacement Therapy Sales Value Share by Application, 2025 VS 2032 & (%) Figure 89. Colombia C1-INH Replacement Therapy Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 90. Colombia C1-INH Replacement Therapy Sales Value Share by Type, 2025 VS 2032 & (%) Figure 91. Colombia C1-INH Replacement Therapy Sales Value Share by Application, 2025 VS 2032 & (%) Figure 92. Peru C1-INH Replacement Therapy Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 93. Peru C1-INH Replacement Therapy Sales Value Share by Type, 2025 VS 2032 & (%) Figure 94. Peru C1-INH Replacement Therapy Sales Value Share by Application, 2025 VS 2032 & (%) Figure 95. Saudi Arabia C1-INH Replacement Therapy Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 96. Saudi Arabia C1-INH Replacement Therapy Sales Value Share by Type, 2025 VS 2032 & (%) Figure 97. Saudi Arabia C1-INH Replacement Therapy Sales Value Share by Application, 2025 VS 2032 & (%) Figure 98. Israel C1-INH Replacement Therapy Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 99. Israel C1-INH Replacement Therapy Sales Value Share by Type, 2025 VS 2032 & (%) Figure 100. Israel C1-INH Replacement Therapy Sales Value Share by Application, 2025 VS 2032 & (%) Figure 101. UAE C1-INH Replacement Therapy Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 102. UAE C1-INH Replacement Therapy Sales Value Share by Type, 2025 VS 2032 & (%) Figure 103. UAE C1-INH Replacement Therapy Sales Value Share by Application, 2025 VS 2032 & (%) Figure 104. Turkey C1-INH Replacement Therapy Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 105. Turkey C1-INH Replacement Therapy Sales Value Share by Type, 2025 VS 2032 & (%) Figure 106. Turkey C1-INH Replacement Therapy Sales Value Share by Application, 2025 VS 2032 & (%) Figure 107. Iran C1-INH Replacement Therapy Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 108. Iran C1-INH Replacement Therapy Sales Value Share by Type, 2025 VS 2032 & (%) Figure 109. Iran C1-INH Replacement Therapy Sales Value Share by Application, 2025 VS 2032 & (%) Figure 110. Egypt C1-INH Replacement Therapy Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 111. Egypt C1-INH Replacement Therapy Sales Value Share by Type, 2025 VS 2032 & (%) Figure 112. Egypt C1-INH Replacement Therapy Sales Value Share by Application, 2025 VS 2032 & (%) Figure 113. Years Considered Figure 114. Research Process Figure 115. Key Executives Interviewed

Scope & coverage.

Types
  • Subcutaneous Injection
  • Intravenous Injection
Applications
  • Acquired Angioedema
  • Hereditary Angioedema
Companies covered
  • CSL Behring
  • Pharming Healthcare
  • Takeda

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global C1-INH Replacement Therapy Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global C1-INH Replacement Therapy Market Size (2021-2032)
  4. 1.4 Assumptions and Limitations
  5. 1.5 Study Goals and Objectives
2 C1-INH Replacement Therapy Market Dynamics
  1. 2.1 C1-INH Replacement Therapy Industry Trends
  2. 2.2 C1-INH Replacement Therapy Industry Drivers
  3. 2.3 C1-INH Replacement Therapy Industry Opportunities and Challenges
  4. 2.4 C1-INH Replacement Therapy Industry Restraints
3 C1-INH Replacement Therapy Market by Company
  1. 3.1 Global C1-INH Replacement Therapy Company Revenue Ranking in 2025
  2. 3.2 Global C1-INH Replacement Therapy Revenue by Company (2021-2026)
  3. 3.3 Global C1-INH Replacement Therapy Company Ranking (2024-2026)
  4. 3.4 Global C1-INH Replacement Therapy Company Manufacturing Base and Headquarters
  5. 3.5 Global C1-INH Replacement Therapy Company Product Type and Application
  6. 3.6 Global C1-INH Replacement Therapy Company Establishment Date
  7. 3.7 Market Competitive Analysis
  8. 3.7.1 Global C1-INH Replacement Therapy Market Concentration Ratio (CR5 and HHI)
  9. 3.7.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  10. 3.7.3 2025 C1-INH Replacement Therapy Tier 1, Tier 2, and Tier 3 Companies
  11. 3.8 Mergers and Acquisitions Expansion
4 C1-INH Replacement Therapy Market by Type
  1. 4.1 C1-INH Replacement Therapy Type Introduction
  2. 4.1.1 Subcutaneous Injection
  3. 4.1.2 Intravenous Injection
  4. 4.2 Global C1-INH Replacement Therapy Sales Value by Type
  5. 4.2.1 Global C1-INH Replacement Therapy Sales Value by Type (2021 VS 2025 VS 2032)
  6. 4.2.2 Global C1-INH Replacement Therapy Sales Value by Type (2021-2032)
  7. 4.2.3 Global C1-INH Replacement Therapy Sales Value Share by Type (2021-2032)
5 C1-INH Replacement Therapy Market by Application
  1. 5.1 C1-INH Replacement Therapy Application Introduction
  2. 5.1.1 Acquired Angioedema
  3. 5.1.2 Hereditary Angioedema
  4. 5.2 Global C1-INH Replacement Therapy Sales Value by Application
  5. 5.2.1 Global C1-INH Replacement Therapy Sales Value by Application (2021 VS 2025 VS 2032)
  6. 5.2.2 Global C1-INH Replacement Therapy Sales Value by Application (2021-2032)
  7. 5.2.3 Global C1-INH Replacement Therapy Sales Value Share by Application (2021-2032)
6 C1-INH Replacement Therapy Regional Value Analysis
  1. 6.1 Global C1-INH Replacement Therapy Sales Value by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global C1-INH Replacement Therapy Sales Value by Region (2021-2032)
  3. 6.2.1 Global C1-INH Replacement Therapy Sales Value by Region: 2021-2026
  4. 6.2.2 Global C1-INH Replacement Therapy Sales Value by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America C1-INH Replacement Therapy Sales Value (2021-2032)
  7. 6.3.2 North America C1-INH Replacement Therapy Sales Value Share by Country, 2025 VS 2032
  8. 6.4 Europe
  9. 6.4.1 Europe C1-INH Replacement Therapy Sales Value (2021-2032)
  10. 6.4.2 Europe C1-INH Replacement Therapy Sales Value Share by Country, 2025 VS 2032
  11. 6.5 Asia-Pacific
  12. 6.5.1 Asia-Pacific C1-INH Replacement Therapy Sales Value (2021-2032)
  13. 6.5.2 Asia-Pacific C1-INH Replacement Therapy Sales Value Share by Country, 2025 VS 2032
  14. 6.6 South America
  15. 6.6.1 South America C1-INH Replacement Therapy Sales Value (2021-2032)
  16. 6.6.2 South America C1-INH Replacement Therapy Sales Value Share by Country, 2025 VS 2032
  17. 6.7 Middle East & Africa
  18. 6.7.1 Middle East & Africa C1-INH Replacement Therapy Sales Value (2021-2032)
  19. 6.7.2 Middle East & Africa C1-INH Replacement Therapy Sales Value Share by Country, 2025 VS 2032
7 C1-INH Replacement Therapy Country-level Value Analysis
  1. 7.1 Global C1-INH Replacement Therapy Sales Value by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global C1-INH Replacement Therapy Sales Value by Country (2021-2032)
  3. 7.2.1 Global C1-INH Replacement Therapy Sales Value by Country (2021-2026)
  4. 7.2.2 Global C1-INH Replacement Therapy Sales Value by Country (2027-2032)
  5. 7.3 USA
  6. 7.3.1 USA C1-INH Replacement Therapy Sales Value Growth Rate (2021-2032)
  7. 7.3.2 USA C1-INH Replacement Therapy Sales Value Share by Type, 2025 VS 2032
  8. 7.3.3 USA C1-INH Replacement Therapy Sales Value Share by Application, 2025 VS 2032
  9. 7.4 Canada
  10. 7.4.1 Canada C1-INH Replacement Therapy Sales Value Growth Rate (2021-2032)
  11. 7.4.2 Canada C1-INH Replacement Therapy Sales Value Share by Type, 2025 VS 2032
  12. 7.4.3 Canada C1-INH Replacement Therapy Sales Value Share by Application, 2025 VS 2032
  13. 7.5 Mexico
  14. 7.5.1 Mexico C1-INH Replacement Therapy Sales Value Growth Rate (2021-2032)
  15. 7.5.2 Mexico C1-INH Replacement Therapy Sales Value Share by Type, 2025 VS 2032
  16. 7.5.3 Mexico C1-INH Replacement Therapy Sales Value Share by Application, 2025 VS 2032
  17. 7.6 Germany
  18. 7.6.1 Germany C1-INH Replacement Therapy Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Germany C1-INH Replacement Therapy Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Germany C1-INH Replacement Therapy Sales Value Share by Application, 2025 VS 2032
  21. 7.7 France
  22. 7.7.1 France C1-INH Replacement Therapy Sales Value Growth Rate (2021-2032)
  23. 7.7.2 France C1-INH Replacement Therapy Sales Value Share by Type, 2025 VS 2032
  24. 7.7.3 France C1-INH Replacement Therapy Sales Value Share by Application, 2025 VS 2032
  25. 7.8 U.K.
  26. 7.8.1 U.K. C1-INH Replacement Therapy Sales Value Growth Rate (2021-2032)
  27. 7.8.2 U.K. C1-INH Replacement Therapy Sales Value Share by Type, 2025 VS 2032
  28. 7.8.3 U.K. C1-INH Replacement Therapy Sales Value Share by Application, 2025 VS 2032
  29. 7.9 Italy
  30. 7.9.1 Italy C1-INH Replacement Therapy Sales Value Growth Rate (2021-2032)
  31. 7.9.2 Italy C1-INH Replacement Therapy Sales Value Share by Type, 2025 VS 2032
  32. 7.9.3 Italy C1-INH Replacement Therapy Sales Value Share by Application, 2025 VS 2032
  33. 7.10 Spain
  34. 7.10.1 Spain C1-INH Replacement Therapy Sales Value Growth Rate (2021-2032)
  35. 7.10.2 Spain C1-INH Replacement Therapy Sales Value Share by Type, 2025 VS 2032
  36. 7.10.3 Spain C1-INH Replacement Therapy Sales Value Share by Application, 2025 VS 2032
  37. 7.11 Russia
  38. 7.11.1 Russia C1-INH Replacement Therapy Sales Value Growth Rate (2021-2032)
  39. 7.11.2 Russia C1-INH Replacement Therapy Sales Value Share by Type, 2025 VS 2032
  40. 7.11.3 Russia C1-INH Replacement Therapy Sales Value Share by Application, 2025 VS 2032
  41. 7.12 Netherlands
  42. 7.12.1 Netherlands C1-INH Replacement Therapy Sales Value Growth Rate (2021-2032)
  43. 7.12.2 Netherlands C1-INH Replacement Therapy Sales Value Share by Type, 2025 VS 2032
  44. 7.12.3 Netherlands C1-INH Replacement Therapy Sales Value Share by Application, 2025 VS 2032
  45. 7.13 Nordic Countries
  46. 7.13.1 Nordic Countries C1-INH Replacement Therapy Sales Value Growth Rate (2021-2032)
  47. 7.13.2 Nordic Countries C1-INH Replacement Therapy Sales Value Share by Type, 2025 VS 2032
  48. 7.13.3 Nordic Countries C1-INH Replacement Therapy Sales Value Share by Application, 2025 VS 2032
  49. 7.14 China
  50. 7.14.1 China C1-INH Replacement Therapy Sales Value Growth Rate (2021-2032)
  51. 7.14.2 China C1-INH Replacement Therapy Sales Value Share by Type, 2025 VS 2032
  52. 7.14.3 China C1-INH Replacement Therapy Sales Value Share by Application, 2025 VS 2032
  53. 7.15 Japan
  54. 7.15.1 Japan C1-INH Replacement Therapy Sales Value Growth Rate (2021-2032)
  55. 7.15.2 Japan C1-INH Replacement Therapy Sales Value Share by Type, 2025 VS 2032
  56. 7.15.3 Japan C1-INH Replacement Therapy Sales Value Share by Application, 2025 VS 2032
  57. 7.16 South Korea
  58. 7.16.1 South Korea C1-INH Replacement Therapy Sales Value Growth Rate (2021-2032)
  59. 7.16.2 South Korea C1-INH Replacement Therapy Sales Value Share by Type, 2025 VS 2032
  60. 7.16.3 South Korea C1-INH Replacement Therapy Sales Value Share by Application, 2025 VS 2032
  61. 7.17 India
  62. 7.17.1 India C1-INH Replacement Therapy Sales Value Growth Rate (2021-2032)
  63. 7.17.2 India C1-INH Replacement Therapy Sales Value Share by Type, 2025 VS 2032
  64. 7.17.3 India C1-INH Replacement Therapy Sales Value Share by Application, 2025 VS 2032
  65. 7.18 Australia
  66. 7.18.1 Australia C1-INH Replacement Therapy Sales Value Growth Rate (2021-2032)
  67. 7.18.2 Australia C1-INH Replacement Therapy Sales Value Share by Type, 2025 VS 2032
  68. 7.18.3 Australia C1-INH Replacement Therapy Sales Value Share by Application, 2025 VS 2032
  69. 7.19 Southeast Asia
  70. 7.19.1 Southeast Asia C1-INH Replacement Therapy Sales Value Growth Rate (2021-2032)
  71. 7.19.2 Southeast Asia C1-INH Replacement Therapy Sales Value Share by Type, 2025 VS 2032
  72. 7.19.3 Southeast Asia C1-INH Replacement Therapy Sales Value Share by Application, 2025 VS 2032
  73. 7.20 Brazil
  74. 7.20.1 Brazil C1-INH Replacement Therapy Sales Value Growth Rate (2021-2032)
  75. 7.20.2 Brazil C1-INH Replacement Therapy Sales Value Share by Type, 2025 VS 2032
  76. 7.20.3 Brazil C1-INH Replacement Therapy Sales Value Share by Application, 2025 VS 2032
  77. 7.21 Argentina
  78. 7.21.1 Argentina C1-INH Replacement Therapy Sales Value Growth Rate (2021-2032)
  79. 7.21.2 Argentina C1-INH Replacement Therapy Sales Value Share by Type, 2025 VS 2032
  80. 7.21.3 Argentina C1-INH Replacement Therapy Sales Value Share by Application, 2025 VS 2032
  81. 7.22 Chile
  82. 7.22.1 Chile C1-INH Replacement Therapy Sales Value Growth Rate (2021-2032)
  83. 7.22.2 Chile C1-INH Replacement Therapy Sales Value Share by Type, 2025 VS 2032
  84. 7.22.3 Chile C1-INH Replacement Therapy Sales Value Share by Application, 2025 VS 2032
  85. 7.23 Colombia
  86. 7.23.1 Colombia C1-INH Replacement Therapy Sales Value Growth Rate (2021-2032)
  87. 7.23.2 Colombia C1-INH Replacement Therapy Sales Value Share by Type, 2025 VS 2032
  88. 7.23.3 Colombia C1-INH Replacement Therapy Sales Value Share by Application, 2025 VS 2032
  89. 7.24 Peru
  90. 7.24.1 Peru C1-INH Replacement Therapy Sales Value Growth Rate (2021-2032)
  91. 7.24.2 Peru C1-INH Replacement Therapy Sales Value Share by Type, 2025 VS 2032
  92. 7.24.3 Peru C1-INH Replacement Therapy Sales Value Share by Application, 2025 VS 2032
  93. 7.25 Saudi Arabia
  94. 7.25.1 Saudi Arabia C1-INH Replacement Therapy Sales Value Growth Rate (2021-2032)
  95. 7.25.2 Saudi Arabia C1-INH Replacement Therapy Sales Value Share by Type, 2025 VS 2032
  96. 7.25.3 Saudi Arabia C1-INH Replacement Therapy Sales Value Share by Application, 2025 VS 2032
  97. 7.26 Israel
  98. 7.26.1 Israel C1-INH Replacement Therapy Sales Value Growth Rate (2021-2032)
  99. 7.26.2 Israel C1-INH Replacement Therapy Sales Value Share by Type, 2025 VS 2032
  100. 7.26.3 Israel C1-INH Replacement Therapy Sales Value Share by Application, 2025 VS 2032
  101. 7.27 UAE
  102. 7.27.1 UAE C1-INH Replacement Therapy Sales Value Growth Rate (2021-2032)
  103. 7.27.2 UAE C1-INH Replacement Therapy Sales Value Share by Type, 2025 VS 2032
  104. 7.27.3 UAE C1-INH Replacement Therapy Sales Value Share by Application, 2025 VS 2032
  105. 7.28 Turkey
  106. 7.28.1 Turkey C1-INH Replacement Therapy Sales Value Growth Rate (2021-2032)
  107. 7.28.2 Turkey C1-INH Replacement Therapy Sales Value Share by Type, 2025 VS 2032
  108. 7.28.3 Turkey C1-INH Replacement Therapy Sales Value Share by Application, 2025 VS 2032
  109. 7.29 Iran
  110. 7.29.1 Iran C1-INH Replacement Therapy Sales Value Growth Rate (2021-2032)
  111. 7.29.2 Iran C1-INH Replacement Therapy Sales Value Share by Type, 2025 VS 2032
  112. 7.29.3 Iran C1-INH Replacement Therapy Sales Value Share by Application, 2025 VS 2032
  113. 7.30 Egypt
  114. 7.30.1 Egypt C1-INH Replacement Therapy Sales Value Growth Rate (2021-2032)
  115. 7.30.2 Egypt C1-INH Replacement Therapy Sales Value Share by Type, 2025 VS 2032
  116. 7.30.3 Egypt C1-INH Replacement Therapy Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 CSL Behring
  2. 8.1.1 CSL Behring Company Information
  3. 8.1.2 CSL Behring Business Overview
  4. 8.1.3 CSL Behring C1-INH Replacement Therapy Revenue and Gross Margin (2021-2026)
  5. 8.1.4 CSL Behring C1-INH Replacement Therapy Product Portfolio
  6. 8.1.5 CSL Behring Recent Developments
  7. 8.2 Pharming Healthcare
  8. 8.2.1 Pharming Healthcare Company Information
  9. 8.2.2 Pharming Healthcare Business Overview
  10. 8.2.3 Pharming Healthcare C1-INH Replacement Therapy Revenue and Gross Margin (2021-2026)
  11. 8.2.4 Pharming Healthcare C1-INH Replacement Therapy Product Portfolio
  12. 8.2.5 Pharming Healthcare Recent Developments
  13. 8.3 Takeda
  14. 8.3.1 Takeda Company Information
  15. 8.3.2 Takeda Business Overview
  16. 8.3.3 Takeda C1-INH Replacement Therapy Revenue and Gross Margin (2021-2026)
  17. 8.3.4 Takeda C1-INH Replacement Therapy Product Portfolio
  18. 8.3.5 Takeda Recent Developments
9 Concluding Insights
    10 Appendix
    1. 10.1 Reasons for Doing This Study
    2. 10.2 Research Methodology
    3. 10.3 Research Process
    4. 10.4 Authors List of This Report
    5. 10.5 Data Source
    6. 10.5.1 Secondary Sources
    7. 10.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst